![](/img/cover-not-exists.png)
Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program
Bookhart, Brahim K., Haskell, Lloyd, Bamber, Luke, Wang, Maria, Schein, Jeff, Mody, Samir H.Volume:
17
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2014.946993
Date:
October, 2014
File:
PDF, 124 KB
english, 2014